Published online Dec 26, 2023. doi: 10.12998/wjcc.v11.i36.8542
Peer-review started: September 8, 2023
First decision: November 9, 2023
Revised: November 29, 2023
Accepted: December 12, 2023
Article in press: December 12, 2023
Published online: December 26, 2023
Processing time: 104 Days and 9.7 Hours
While stroke and lower extremity venous thromboemboli have been commonly reported following acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spinal cord infarction or ischemia has been extremely rare. Findings of long coronavirus disease (COVID) in this select population have not been studied.
We present the case of a 70-year-old female with sudden onset of trunk and lower extremity sensorimotor loss due to spinal cord infarction, attributed to acute infection with SARS-CoV-2. Diagnostic work up confirmed a T3 complete (ASIA impairment Scale A) paraplegia resulting from a thrombotic infarct. Her reported myalgias, neuropathic pain, spasticity, bladder spasms, and urinary tract infections exceeded the frequency and severity of many spinal cord injury (SCI) individuals of similar age and degree of neurologic impairment. In her first year after contracting COVID-19, she underwent 2 separate inpatient rehabilitation courses, but also required acute hospitalization 6 additional times for subsequent infections or uncontrolled pain. Yet other complications of complete non-traumatic SCI (NTSCI), including neurogenic bowel and temperature hypersensitivity, were mild, and pressure injuries were absent. She has now transitioned from the acute to chronic phase of spinal cord injury care, with subsequent development of post-acute sequelae of SARS-CoV-2 infection (PASC).
This individual experienced significant challenges with the combined effects of acute T3 NTSCI and acute COVID-19, with subsequent progression to PASC.
Core Tip: Although stroke and venous thromboembolism have been frequently observed with acute coronavirus disease 2019 (COVID-19), spinal cord infarction leading to paraplegia has rarely been seen. We report a case of spinal cord infarction shortly following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Consequently, this individual has experienced severe neurologic disability, with subsequent development of long COVID. Symptoms such as myalgias, neuropathic pain, muscle spasms, and frequent bacterial infections are present in post-acute sequelae of SARS-CoV-2 infection (PASC), independent of spinal cord injury (SCI). Over the past 3 years, the dual presence of PASC and recent SCI may have led to increased severity of symptoms shared by both conditions.